亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Efficacy of Upfront Docetaxel With Androgen Deprivation Therapy for Castration-Sensitive Metastatic Prostate Cancer Among Minority Patients

医学 雄激素剥夺疗法 前列腺癌 危险系数 多西紫杉醇 内科学 肿瘤科 比例危险模型 置信区间 癌症
作者
Surabhi Pathak,Romy Jose Thekkekara,Udit Yadav,Ahmed Tarig Ahmed,Barbara Yim,Thomas E. Lad,Michael Russell Mullane,Kumar Kunnal Batra,Wilbert S. Aronow,Sarah P. Psutka
出处
期刊:American Journal of Therapeutics [Lippincott Williams & Wilkins]
卷期号:28 (4): e380-e387 被引量:2
标识
DOI:10.1097/mjt.0000000000001085
摘要

Upfront docetaxel (UD) with androgen deprivation therapy (ADT) has been demonstrated to improve survival outcomes in metastatic castration-sensitive prostate cancer (mCSPC). However, existing studies have included predominantly Caucasian patients.To compare the efficacy of addition of UD to ADT in mCSPC to ADT alone among minority patients.Retrospective study of mCSPC patients.Patients treated with UD and ADT between January 2014 and December 2017 (UD + ADT, n = 44) were compared with those treated with ADT alone between January 2008 and January 2017 (ADT, n = 38); patients of Caucasian ethnicity were excluded. The outcome of interest was progression-free survival (PFS), which was estimated using Kaplan-Meier analysis and Cox proportional hazard analysis.Overall, 63 (76.8%) patients were African American and 16 (19.5%) were Hispanic. Fifty-five (67%) patients had high-volume mCSPC. The median follow-up was 14 months [95% confidence interval (CI): 10.4-16.5] for UD + ADT and 42 months (95% CI: 17-66.9) for ADT. Median PFS did not differ between groups: UD + ADT: 16 versus ADT: 18 months [hazard ratio (HR) for UD + ADT = 0.88, 95% CI: 0.48-1.62; P = 0.70]. In patients with high-volume disease, median PFS remained similar (UD + ADT: 16 vs. ADT: 14 months (HR for UD + ADT = 0.64, 95% CI: 0.33-1.25; P = 0.19). On multivariable analysis, prolonged time to nadir PSA, HR = 0.83 (95% CI: 0.76-0.90), was independently associated with PFS. The most common toxicities in UD + ADT were anemia and fatigue. Major limitations include small sample size and potential for selection bias due to the retrospective study design.In this retrospective review of a minority mCSPC cohort, UD + ADT was not associated with improved PFS compared with ADT alone. Although further study with larger sample size is needed, these results underscore the importance of ensuring accrual of minorities in clinical trials, reflective of the real-world setting.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英姑应助曾泰平采纳,获得10
5秒前
13秒前
在水一方应助典雅的芷珍采纳,获得10
16秒前
曾泰平发布了新的文献求助10
19秒前
34秒前
Desmend发布了新的文献求助10
40秒前
怡然咖啡豆完成签到,获得积分10
48秒前
Akim应助科研通管家采纳,获得10
51秒前
英俊的铭应助科研通管家采纳,获得10
51秒前
52秒前
1分钟前
方勇飞发布了新的文献求助10
1分钟前
1分钟前
打打应助归海亦云采纳,获得10
1分钟前
1分钟前
1分钟前
量子星尘发布了新的文献求助10
1分钟前
归海亦云发布了新的文献求助10
1分钟前
科研小白完成签到 ,获得积分10
1分钟前
归海亦云完成签到,获得积分10
1分钟前
2分钟前
DING发布了新的文献求助20
2分钟前
2分钟前
Desmend发布了新的文献求助10
2分钟前
Desmend完成签到,获得积分20
2分钟前
整点奶茶喝喝完成签到,获得积分10
2分钟前
慕青应助DING采纳,获得10
2分钟前
方勇飞发布了新的文献求助10
2分钟前
传奇3应助曾泰平采纳,获得10
2分钟前
汉堡包应助科研通管家采纳,获得10
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
GPTea应助美好的麦片采纳,获得20
2分钟前
曾泰平发布了新的文献求助10
2分钟前
3分钟前
沉静从安发布了新的文献求助10
3分钟前
华仔应助难过的踏歌采纳,获得10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Einführung in die Rechtsphilosophie und Rechtstheorie der Gegenwart 1500
Binary Alloy Phase Diagrams, 2nd Edition 1000
青少年心理适应性量表(APAS)使用手册 700
Air Transportation A Global Management Perspective 9th Edition 700
Socialization In The Context Of The Family: Parent-Child Interaction 600
DESIGN GUIDE FOR SHIPBOARD AIRBORNE NOISE CONTROL 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4994994
求助须知:如何正确求助?哪些是违规求助? 4242304
关于积分的说明 13215918
捐赠科研通 4038092
什么是DOI,文献DOI怎么找? 2209512
邀请新用户注册赠送积分活动 1220307
关于科研通互助平台的介绍 1139071